CCDC22 helps cells sort and recycle proteins after they enter the cell, which supports normal growth and brain development. When the CCDC22 gene does not work properly, this internal transport system can be disrupted, and some people may have developmental delay, learning difficulties, or differences affecting growth, hearing, or the heart. Pathogenic variants in the CCDC22 gene are uncommon and often follow an X linked inheritance pattern. Many variants are harmless, while a few may change how the gene works.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or direct processes in the body. In some genes, those instructions are for producing proteins, the parts of cells that do much of the work. Other genes are used mainly to regulate when certain processes happen, where they happen, and how strongly they occur. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this topic in greater depth, you can find more in the LearnHub.
Overview
CCDC22Gene function
What if the gene works
The CCDC22 gene helps cells sort and recycle proteins after they are brought inside. This supports normal cell signaling and helps many tissues develop and work as expected.
Risk
What if the gene does not work
Variants in the CCDC22 gene can cause an X linked developmental condition with intellectual disability, often along with speech, facial, heart, or genital differences. Milder and more severe variants can influence which features appear and how marked they are.
Treatment
What does that mean for your treatment
For a pathogenic or loss-of-function variant in the CCDC22 gene, no treatment or drug choice approach specific to the CCDC22 gene is currently established. Care is guided by the person’s symptoms and supportive therapies, not by a medicine aimed at this gene.
Conditions associated with CCDC22
Gene function
What if the gene works
Inside your cells, proteins are constantly being moved, sorted, and returned to the places where they are needed. The CCDC22 gene helps coordinate this internal traffic, especially during protein recycling inside cells. When it works as expected, cells can keep many surface proteins in the right place and reuse them efficiently.
The CCDC22 gene helps cells manage endosomes, which are small compartments that sort proteins after use. It supports the choice to send some proteins back for reuse rather than toward breakdown.
Working with partner proteins, the CCDC22 gene helps return selected proteins to the cell surface. This keeps receptors and transporters available so cells can respond to signals and move materials in a controlled way.
Inside your cells, the CCDC22 gene supports the movement of protein cargo between recycling compartments. This steady flow helps many tissues maintain everyday cell communication and nutrient handling.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. Variants are common and are part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CCDC22 gene can make the protein less stable or weaken how it joins the cell's trafficking machinery, especially the CCC complex involved in endosomal sorting. How CCDC22 gene variants affect protein function depends on the change: milder variants may leave partial activity, while more disruptive variants can greatly reduce the protein or its interactions. Stronger functional disruption is often linked to wider cellular effects and, in some people, earlier developmental features.
How variants are linked to conditions
Pathogenic variants in the CCDC22 gene can cause an X linked developmental condition, and some affected people are diagnosed with Ritscher Schinzel syndrome 2. Reported CCDC22 gene variants are linked to developmental delay and intellectual disability, with some people also having hearing loss, short stature, and heart or brain differences found during medical evaluation. Because this condition involves the X chromosome, males are often more clearly affected, while some females may have milder features.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely found in the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a definitive diagnosis, particularly when several genes and environmental factors play a role. In some situations, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CCDC22 gene. For many living with a CCDC22 gene change, the main factor is the genetic change itself rather than lifestyle or environmental exposures, and personal risk is best discussed with a doctor or genetic counselor.
Inheritance of CCDC22 variants
CCDC22-related conditions are usually inherited in an X-linked pattern. Because the CCDC22 gene sits on the X chromosome, the way a CCDC22 gene variant is inherited differs for sons and daughters: a mother carrying the variant can pass it to either sex, while a father passes his X chromosome only to daughters, not to sons. Many affected people are male because males have one X chromosome, while females with one altered copy may have no symptoms or milder features.
What does my CCDC22 result mean for my family?
For families with a disease-causing change in the CCDC22 gene, the pattern is usually X-linked. This means related males on the mother's side may be more likely to be affected, while some female relatives may carry the change and can sometimes have milder features or none at all. Close family members may want to learn whether the same gene change is present in the family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the CCDC22 gene uses a blood sample, saliva sample, or cheek swab to read your DNA. It can find a variant linked to a confirmed genetic diagnosis, show a variant of uncertain significance, or find no relevant change, depending on the test method used.
When should I consider getting a genetic test?
Genetic testing for the CCDC22 gene may be worth considering when a child has unexplained developmental delay or intellectual disability, especially along with low muscle tone, hearing loss, or birth differences. It can also be helpful when similar concerns run in the family, particularly in boys or men on the mother’s side.
A genetic result is only one part of your health story
Genetic results can offer useful insight, but how much they reveal depends on the condition and the specific type of variant. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at the target tissue. This helps explain why the same medication may work well for one person, work less well for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that looks at how genetic differences affect responses to medications. It examines connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes can influence how strongly a drug works or how the body handles it. This information can help support more informed and individualized treatment decisions. You can learn more about this topic in the LearnHub.
Drugs influenced by the CCDC22 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so general health concerns or questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
CCDC22 entered the medical literature through studies of families in which several relatives shared developmental and learning differences, especially in patterns suggesting X linked inheritance. In recent decades, awareness of this gene’s role has grown as researchers connected rare CCDC22 variants with a recognizable inherited condition first described in affected families. From these first observations, research expanded steadily, and later studies placed the CCDC22 gene within a broader group of genes involved in cell trafficking pathways. This helped clinicians understand why people with variants in CCDC22 can show overlapping features even when the exact presentation differs from one family to another. The history of CCDC22 is mainly a story of careful family studies followed by modern genetic sequencing that clarified the cause.